Kneizeh, K.; Milzi, A.; Vogt, F.; Witte, K.; Marx, N.; Lehrke, M.; Almalla, M.; Schröder, J.
Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison. J. Clin. Med. 2023, 12, 4243.
https://doi.org/10.3390/jcm12134243
AMA Style
Kneizeh K, Milzi A, Vogt F, Witte K, Marx N, Lehrke M, Almalla M, Schröder J.
Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison. Journal of Clinical Medicine. 2023; 12(13):4243.
https://doi.org/10.3390/jcm12134243
Chicago/Turabian Style
Kneizeh, Kinan, Andrea Milzi, Felix Vogt, Klaus Witte, Nikolaus Marx, Michael Lehrke, Mohammad Almalla, and Jörg Schröder.
2023. "Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison" Journal of Clinical Medicine 12, no. 13: 4243.
https://doi.org/10.3390/jcm12134243
APA Style
Kneizeh, K., Milzi, A., Vogt, F., Witte, K., Marx, N., Lehrke, M., Almalla, M., & Schröder, J.
(2023). Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison. Journal of Clinical Medicine, 12(13), 4243.
https://doi.org/10.3390/jcm12134243